Analysis of tumors from ccRCC patients and pVHL loss-of-function mutations confirmed pVHL loss usually increases the abundance and nuclear levels of ZHX2 in ccRCC tumors. This evidence concerns the gene ZHX2 and nonpapillary renal cell carcinoma.